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Acinetobacter baumannii (Ab) is one of the most treacherous pathogens among those
causing hospital-acquired pneumonia (HAP). A. baumannii possesses an adaptable
physiology, seen not only in its antibiotic resistance and virulence phenotypes but also in
its metabolic versatility. In this study, we observed that A. baumannii undergoes global
transcriptional changes in response to human pleural fluid (PF), a key host-derived
environmental signal. Differential gene expression analyses combined with experimental
approaches revealed changes in A. baumannii metabolism, affecting cytotoxicity,
persistence, bacterial killing, and chemotaxis. Over 1,220 genes representing 55% of
the differentially expressed transcriptomic data corresponded to metabolic processes,
including the upregulation of glutamate, short chain fatty acid, and styrene metabolism.
We observed an upregulation by 1.83- and 2.61-fold of the pyruvate dehydrogenase
complex subunits E3 and E2, respectively. We also found that pyruvate (PYR), in
conjunction with PF, triggers an A. baumannii pathogenic behavior that adversely
impacts human epithelial cell viability. Interestingly, PF also amplified A. baumannii
cytotoxicity against murine macrophages, suggesting an immune evasion strategy
implemented by A. baumannii. Moreover, we uncovered opposing metabolic strategies
dependent on the degree of pathogenicity of the strains, where less pathogenic strains
demonstrated greater utilization of PYR to promote persister formation in the presence
of PF. Additionally, our transcriptomic analysis and growth studies of A. baumannii
suggest the existence of an alternative phenylalanine (PA) catabolic route independent of
the phenylacetic acid pathway, which converts PA to phenylpyruvate (PP) and shuttles
intermediates into styrene metabolism. This alternative route promoted a neutrophil-
evasive state, as PF-induced degradation of PP significantly reduced overall human
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neutrophil chemotaxis in ex vivo chemotactic assays. Taken together, these data
highlight A. baumannii pathoadaptabililty in response to host signals and provide further
insight into the role of bacterial metabolism in virulence traits, antibiotic persistence
strategies, and host innate immune evasion.
Keywords: Acinetobacter baumannii, metabolism, immunoevasion, pleural fluid, pyruvate, phenylalanine,
antibiotic resistance
INTRODUCTION
Acinetobacter baumannii is a notorious nosocomial pathogen
with mortality rates among patients in intensive care units
reported between 21.6 and 67% (Falagas et al., 2006; Peleg et al.,
2008; Roca et al., 2012; Park et al., 2013; Inchai et al., 2015; Xiao
et al., 2017). A. baumannii is responsible for a high number
of health-care-associated cases of pneumonia, bacteremia, and
urinary, skin, or surgical-derived infections (Peleg et al., 2008;
Roca et al., 2012; Wong et al., 2017). This Gram-negative
bacterium has also garnered considerable clinical significance
as a result of its intrinsic antibiotic resistance mechanisms,
innate ability to persist for long periods upon desiccation
and starvation, and capability to acquire foreign resistance
determinants from the surrounding environment (Jawad et al.,
1998; Peleg et al., 2008; Adams et al., 2010; Sahl et al., 2013;
Chapartegui-Gonzalez et al., 2018). Because of its growing
antibiotic resistance profile, the World Health Organization
(WHO) has assigned A. baumannii a threat level “critical” on
the Priority Pathogens List for new antimicrobial research and
development (WHO, 2017).
Apart from its dynamic antibiotic resistance, A. baumannii
has also been shown to be extremely persistent under many
conditions (Jawad et al., 1998; Roca et al., 2012; Mortensen and
Skaar, 2013; Juttukonda et al., 2016). Unique among Gram-
negative pathogens, A. baumannii persists for a prolonged period
of time in the environment and during patient colonization
in spite of antimicrobial exposure, nutrient deprivation, or the
presence of immune effectors. Modifications in metabolism and
nutritional needs have been linked to the ability of A. baumannii
to persist and adapt to a hostile host environment (Mortensen
and Skaar, 2013). In fact, A. baumannii metabolic flexibility was
shown to overcome host nutrient limitation via urea carboxylase-
induced calprotectin resistance; differential expression of zur
and fur transcriptional regulators; upregulation of Mn2+, Zn2+,
Fe3+ uptake systems; and increased secretion of iron-scavenging
siderophores (Juttukonda et al., 2016). Additionally, cytolytic
activity and immunoevasive mechanisms of A. baumannii have
also been linked to metal acquisition and phenylacetic acid (PAA)
metabolism (Bhuiyan et al., 2016; Fiester et al., 2016).
Pathogens maintain a balance between virulence and
persistence during host infection to succeed while competing
for nutritional factors and host immune effectors and secreting
advantageous toxins and proteins. Human serum albumin
(HSA), the main blood protein component and an important
marker of host nutritional and inflammatory status, triggers the
differential expression of a number of key genes involved in the
survival and persistence of A. baumannii (Don and Kaysen, 2004;
Quinn et al., 2018b). Pleural fluid (PF), an HSA-containing
medium that primarily functions to lubricate pleurae during
respiratory movements, is continuously produced by intercostal
arteries and removed by the lymphatic system. Disruption of this
flow can result in an abnormal amount of fluid in the chest cavity
known as a pleural effusion, a frequent sign of underlying disease
to which bacterial pneumonia constitutes the second leading
cause in the United States with an annual incidence of 300,000
(Light, 2006). Hospitalized patients diagnosed with bacterial
pneumonia, one of the most common clinical manifestations
of A. baumannii, in 40% of cases develop pleural effusion
(Chen et al., 2001; Costa et al., 2001; Joly-Guillou, 2005; Light,
2006). Accordingly, PF constitutes a host component that this
nosocomial pathogen is in many instances obliged to cope with.
Both the previously reported signaling properties of HSA and
the presence of immune cells and effectors in PF contents lead
us to hypothesize that PF provides a diverse set of environmental
cues for bacterial adaptation to harsh conditions within the
host. Therefore, we investigated the notion that PF could trigger
adaptive responses in the pathophysiology of A. baumannii
during respiratory infection. In this study, we aimed to assess
changes in the metabolic profile of A. baumannii upon exposure
to PF and their possible role in the establishment of survival
strategies. To test our hypothesis, three model strains (A118, A42,
and AB5075) with varying degrees of antibiotic susceptibility and
virulence were used (Ramirez et al., 2010; Ramirez et al., 2011;
Vilacoba et al., 2013; Jacobs et al., 2014; Traglia et al., 2016). A118,
the least antibiotic-resistant and virulent strain, was selected to
perform transcriptomic analysis, metabolic microarrays, and
virulence testing as the strain has been previously used as a model
system (Ramirez et al., 2010; Ramirez et al., 2012; Traglia et al.,
2016; Domingues et al., 2018; Martinez et al., 2018; Quinn et al.,
2018a,b,c; Domingues et al., 2019). A42, the mildly resistant and
virulent strain, and AB5075, the most resistant and virulent, were
then used to supplement our assessment of the A. baumannii
metabolic profile in response to PF. Our findings revealed unique
insights into the complexity of metabolic adaptive responses
in this pathogen.
MATERIALS AND METHODS
Bacterial Strains, Mammalian Cell Lines,
and Human Fluid
Acinetobacter baumannii A118, A42, and AB5075 strains
were used (Ramirez et al., 2011; Jacobs et al., 2014; Quinn
et al., 2018a,c) as bacterial models (Ramirez et al., 2010;
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TABLE 1 | Characteristics of the strains used in the study.
Strain Site of isolation Virulence Resistance References
A118 Blood Low virulence Highly susceptible Ramirez et al., 2010
A42 Endotracheal aspirate Mildly virulent Multidrug resistant Vilacoba et al., 2013
AB5075 Tibia/Osteomyelitis Extremely virulent Extremely drug resistant Jacobs et al., 2014
Jacobs et al., 2012; Ramirez et al., 2012; Jacobs et al., 2014;
Traglia et al., 2016; Quinn et al., 2018a,c; Table 1). Escherichia
coli-TET-R and Staphylococcus aureus USA300 were also used
in pathogenicity-determining experiments (Knauf and Nester,
1982; Diekema et al., 2014). Bacterial cells were plated from -
80◦C storage on cystine lactose electrolyte deficient (CLED) agar
and later cultured in Luria–Bertani (LB) broth at 37◦C and/or the
different tested conditions.
American Type Culture Collection (ATCC) HeLa cells
and RAW 264.7 macrophages were used for cytotoxicity
assay. Cell lines were routinely grown in Dubelcco’s modified
Eagle’s minimum essential medium (DMEM) (Invitrogen),
supplemented with 10% (v/v) fetal calf serum (ATCC, Manassas,
VA, United States) as well as penicillin/streptomycin and
incubated at 37◦C in 5% CO2 humidified atmosphere. Human
neutrophils were obtained from a certified vendor (Astarte
Biologicals Inc., Bothell, WA, United States) and used for the
neutrophil chemotaxis assay.
The human PF sample used in the present study was acquired
from Innovative Research, MI, which is a certified vendor that
obtains human samples from Food and Drug Administration
(FDA)-approved facilities. LB supplemented with 4% PF was
used for all PF conditions; the concentration was previously
established in Martinez et al. (2018). The ability of A118 to grow
in 100% PF was assessed, and it was observed that A118 can grow
in 100% of this human fluid (data not shown).
All procedures performed in this study were in accordance
with the CSUF Institutional Biosafety Committee Approval
plan (DBH117-01) and are in compliance with the National
Institutes of Health (NIH), Centers for Disease Control
and Prevention (CDC), Occupational Safety and Health
Administration (OSHA0), and other environmental and
occupational regulations.
RNA Extraction, Sequencing, and
Transcriptomic Analysis
In 2010, the strain A118 was established as a study model,
and it has recently been used for transcriptomic analysis for a
human component; this led us to select it for transcriptomic
analysis in the presence of PF (Ramirez et al., 2010; Quinn et al.,
2018b). A118 cells were cultured in LB broth with or without
PF and incubated with agitation for 18 h at 37◦C. Overnight
cultures were then diluted 1:10 in fresh LB broth and incubated
with agitation for 7 h at 37◦C. RNA was immediately extracted
following the TRI REAGENT R©Kit (Molecular Research Center,
Inc., Cincinnati, OH, United States) as previously described
(Quinn et al., 2018b).
RNA sequencing was outsourced to Novogene (Novogene
Corporation, CA, United States) for mRNA-seq analysis,
which includes rRNA depletion, library preparation through
Next R©UltraTM RNA Library Prep Kit for Illumina (New England
Biolabs), and HiSeq 2500 paired-end 150 base pair (bp)
sequencing. Trimming of low-quality bases at the ends of
the reads to a minimum length of 100 bp and removal of
Illumina adaptor sequences were performed using Trimmomatic
(version 0.32). Quality of the reads before and after trimming
was assessed using FastQC1. Reads were then aligned to the
contigs of the genome of A. baumannii A118 strain using
the Burrows–Wheeler Alignment (BWA) software (Li and
Durbin, 2010), yielding >91% unambiguously mapped reads
per library. Alignments were visualized using the Integrated
Genome Viewer software (Thorvaldsdottir et al., 2013). Read
counts per gene were calculated using FeatureCounts (Quinlan
and Hall, 2010), and differential expression analysis was
performed using DEseq (Anders and Huber, 2010). Both
principal component analysis (PCA) and gene expression
heat map with clustering dendrograms of the RNA-seq data
analysis showed that the biological replicates of LB and PF
treatments were effectively clustered into two well-defined groups
(Supplementary Figure S1). Transcriptomic data of metabolic-
related genes were considered for the present study. Features
exhibiting false discovery rate (FDR) <0.05 were considered
statistically significant.
RNA-seq data generated as a result of this work have been
deposited to Gene Expression Omnibus (GEO) with the accession
number GSE131949.
Phenotype Microarray Assay and
Analysis
Bacterial strains were cultured in LB and LB + 4% PF at
37◦C for 18 h. Inoculation and preparation were performed via
manufacturer instructions (Biolog, Hayward, CA, United States)
with exception of using isolated cells from overnight culture
to inoculate sole carbon sources. PM1, PM2A (both carbon
sources), and PM3 (nitrogen source) were used. Plates were
incubated under aerobic conditions for 24 h at 37◦C, and
results were read at OD590 using the multimodal plate
reader SpectraMax3.
Cell-Free Culture Media Preparation
Cell-free culture media (CFCM) was obtained as previously
described by allowing A. baumannii strains to grow for 48 h at
37◦C under shaking conditions (200 rpm) in LB, PF, LB + 1%
pyruvate (PYR), PF + 1% PYR, LB + 0.02% phenylalanine
(PA), PF + 0.02% PA, LB + 0.02% PAA, PF + 0.02% PAA,
LB + 0.02% phenylpyruvate (PP), PF + 0.02% PP, and culture
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
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(Ramsey et al., 2016; Castellanos et al., 2019). At the end of
the incubation period, bacterial cultures were centrifuged for
10 min at 7,000 × g. The supernatant was filtered through a
Steriflip Vacuum Filtration System with Millipore Express PLUS
Membrane (0.22 µm) (Millipore, #SCGP00525).
PYR (1%) was used, since it was previously shown to induce
a significant increase in the exoproteome profile of S. aureus,
enhancing its pathogenicity (Harper et al., 2018); 0.02% PA, PAA,
and PP CFCM were used due to the minimal growth seen in A118
growth curves of PAA with or without PF in both minimal media
growth curves and in LB. To be consistent, 0.02% was used in
CFCM studies for all three conditions.
Cytotoxicity Assay
The CFCM of A118 LB, PF, LB + 1% PYR, and PF + 1%
PYR were collected and diluted with colorless DMEM to 0.2–
50% CFCM. ATCC HeLa cells and RAW 264.7 macrophages
were diluted to a final concentration of 1 × 106 cells/ml
in colorless DMEM. HeLa and RAW suspensions were then
added in a final volume of 50 µl/well to NunclonTM Delta
Surface opaque 96-well microplate (ThermoScientific). HeLa
and RAW cells were then intoxicated for 1 h at 37◦C, 5%
CO2, with 50 µl of experimental CFCM conditions. CellTiter-
Glo R©Reagent was prepared according to the manufacturer’s
instructions (Promega, Madison, WI, United States), and
adenosine triphosphate (ATP) (Sigma) was resuspended in
colorless DMEM to generate a standard curve. CellTiter-
Glo R©Reagent (100 µl) was added to each experimental and
standard curve well and then placed on an orbital shaker
for 2 min. Following mixing, plates were incubated at
room temperature for 10 min to stabilize the luminescent
signal. The viability of RAW and HeLa cells was measured
at room temperature using the “all” luminescence function
of SpectraMax M3.
Dehydrogenase Activity Assays of Cell
Soluble Extracts
Dehydrogenase activity was measure in cell soluble extracts
of A118 strains with and without PF. Aliquots (1 ml) were
pelleted and resuspended in 80 µl of resuspension buffer
(100 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES), 1 M MgCl2, pH 7.5). Soluble extracts treated with
0.8 mg lysozyme were added, and samples were incubated at
37◦C for 30 min. Samples were centrifuged at 12,000 rpm
for 10 min at 4◦C. For malate dehydrogenase (MDH) activity,
16 µl of supernatant was added to 184 µl of forward
reaction buffer (100 mM HEPES pH 7.5, 10 mM NAD+,
100 mM L-malic acid, 1 mM DTT, 10 mM MgCl2) per
well. To test 2-oxoglutarate dehydrogenase, α-ketoglutaric acid
(100 mM) was added instead of L-malic acid. All dehydrogenase
assays were conducted in triplicate. The absorbance was
analyzed using spectrophotometric analysis (SpectraMax M3)
at 30◦C with an excitation of 340 nm and an emission of
460 nm. Measurements were taken at time 0 and 10 min
later. During that 10 min, the plate was stored in an
incubator at 37◦C.
Persistence Assay
The persistence assay was performed as described previously
(Muller et al., 2017) with slight modifications. Briefly, A118,
A42, and AB5075 overnight cultures (stationary-phase cultures)
grown in LB, PF, LB + 1% PYR, and PF + 1% PYR were
treated with ofloxacin (OFX) at a final concentration of 3X
MIC (µg/ml) for 5 h at 37◦C in 96 multiwell microplates.
A control treatment with sterile water was performed in parallel.
The number of colony-forming units (CFUs) was determined
by plate counts in each case. The persister fraction is defined
as the number of surviving cells after treatment with OFX
divided by the number of cells after control treatment (water).
The experiments were performed in triplicate. Statistical analysis
(Mann–Whitney test) was performed using GraphPad Prism
(GraphPad software, San Diego, CA, United States). A P-
value< 0.05 was considered significant.
Bacterial Killing Assay
Killing assays were carried out as previously described with minor
changes (Weber et al., 2015; Quinn et al., 2018b). Briefly, A118
and E. coli-TET as predator and prey, respectively, were used.
A118 LB, PF, LB + 1% PYR, PF + 1% PYR, and E. coli cultures
were grown and normalized. A118 in the different conditions and
E. coli were mixed at a predator–prey 1:1 ratio, and 5 µl was
spotted on a dry LB agar plate. After 4 h, the spot was resuspended
in 1 ml of PBS and 10-µl serial dilutions were plated on LB
agar plate with tetracycline (30 µg/ml). Growth of the prey was
recorded after incubation at 37◦C for 24 h.
Aromatic Sugar and Carboxylic Acid
Utilization Assays
Cultures were grown in LB broth induced with or without
PF overnight in 37◦C with shaking. Growth assays were
conducted on 96-well plates in triplicate in Minimal Medium M9
supplemented with 1 µM MgSO4, with 0.2% PA, 0.2% PAA, 0.2%
PP, 0.2% fumarate, 0.2% malate, and 0.2% succinate. Additional
nutrient assays were conducted in LB supplemented with 1%
PYR, 0.2% PAA, 0.2% PA, 0.2% PP, 0.02% PA, 0.02% PAA, and
0.02% PP. Wells containing 294 µl of media and 6 µl of culture
were incubated for 18 h in 37◦C with medium shaking. Growth
was measured at OD600 every 20 min. Mann–Whitney test was
performed for statistical analysis.
Quantitative Reverse Transcription
Polymerase Chain Reaction (qPCR)
Previously extracted and DNase-treated RNA from A. baumannii
strain A118 grown in LB or 4% PF were synthesized to
cDNA using the manufacturer protocol provided within the
iScriptTM Reverse Transcription Supermix for qPCR (Bio-Rad,
Hercules, CA, United States). The cDNA concentrations were
measured with a DeNovix DS-11+ spectrophotometer; each
sample was then diluted to a concentration of 50 ng/µl. qPCR was
conducted using the iQTM SYBR R©Green Supermix through the
manufacturer’s instructions. At least three biological replicates
of cDNA were used and were run in quadruplet. All samples
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were then run on the CFX96 TouchTM Real-Time PCR Detection
System (Bio-Rad, Hercules, CA, United States).
The transcript levels of each sample were normalized to the
recA rRNA transcript levels for each cDNA sample. The relative
quantification of gene expression was performed using the
comparative threshold method 2−11Ct. The ratios obtained after
normalization were expressed as folds of change compared with
cDNA samples isolated from bacteria cultures on LB. Statistical
analysis (Mann–Whitney test) was performed using GraphPad
Prism (GraphPad software, San Diego, CA, United States). A P-
value< 0.05 was considered significant.
Neutrophil Chemotaxis Assay
The neutrophil chemotaxis assay was performed as described
previously with slight modifications (Henkels et al., 2011; Kaur
and Singh, 2013; Bhuiyan et al., 2016). Herein, 25 ml of Roswell
Park Memorial Institute Medium (RMPI; Thermo Fisher 22400),
2.5 ml fetal bovine serum (FBS; Thermo Fisher A3160601),
500 µl of 100 U/ml penicillin–streptomycin, and 22 ml of
Hanks’ balanced salt solution (HBSS; Thermo Fisher 14025)
were combined to make the chemotaxis buffer. Twenty-four-well
Olympus polycarbonate tissue culture plates with 8-µm pore size
membranes were used (Genesee Cat #25-289). The chemotaxis
buffer (200 µl) was combined with 200 µl of CFCM of each
condition. Eight different A118 CFCM conditions were tested: LB
only, PF+ LB, 0.02% PA in LB, 0.02% PAA in LB, 0.02% PP in LB,
0.02% PA in PF + LB, 0.02% PAA in PF + LB, and 0.02% PP in
PF + LB. A control treatment of each of the medium conditions
without CFCM was performed in parallel. Neutrophils (200 µl;
105 cells/ml) were added to the semipermeable well inserts. The
plate was incubated for 1 h in 5% atmospheric CO2 at 37◦C.
Cells were counted from 20-µl representative samples of each
well. Chemotaxis index was calculated by dividing the number
of neutrophils in the test well by the number of neutrophils in the
control well. The experiments were performed in triplicates.
Statistical Analysis
Data are expressed as mean ± standard deviation (SD).
Statistical analyses [Mann–Whitney test, multiple t-test, one-
way analysis of variance (ANOVA), and two-way ANOVA]
were performed using GraphPad Prism (GraphPad software, San
Diego, CA, United States). A P-value < 0.05 was considered
significant. All reported results are statistically significant unless
otherwise stated.
RESULTS
PF Shifts Metabolic Gene Expression of
A. baumannii Strain A118
Transcriptome analysis of A. baumannii strain A118 in the
presence of human PF revealed a comprehensive differential
profile of 2,232 genes with an FDR-adjusted P-value < 0.05
(Supplementary Figure S2). Consistent with the composition
complexity of PF, this transcriptional response was notably
more pronounced than that of the 111 statistically significant
differentially expressed genes (DEGs) previously observed in
strain A118 exposed to HSA (Quinn et al., 2018b). Genes
associated with metabolic processes represented more than 55%
of our DEGs (n = 2,232). Genes involved in glutamate, short
chain fatty acid, and styrene metabolism, as well as the PYR
dehydrogenase complex were upregulated.
PF Promotes Conversion of PYR to
Specific Metabolic Precursors
We observed an interesting effect in the expression of genes
associated to PYR metabolism in our transcriptomic data. We
found that under PF exposure, the expression of genes peg.2461–
63 encoding three components of the pyruvate dehydrogenase
(PDH) complex were upregulated (Supplementary Table S1).
The PDH complex of A. baumannii, which is responsible
for acetyl-CoA production, is composed of three subunits:
PDH (E1), dihydrolipoamide acetyltransferase subunit (E2), and
the dihydrolipoamide dehydrogenase subunit (E3). The gene
encoding the E1 subunit of the PDH complex, aceE, was
upregulated by a fold change of 2.03, and the E2 subunit,
aceF, was upregulated by a fold change of 2.61 (Supplementary
Table S1). qPCR confirmed these results (Figures 1A,B), thus
supporting that conversion of PYR into acetyl-CoA production
is indeed favored in the presence of PF (Figure 1C).
Given that acetyl-CoA is a significant metabolite for fatty acid
synthesis, these latter PF-mediated transcriptional effects could,
in principle, increase A. baumannii lipid metabolism. However,
we observed that the expressions of many of the enzymes
involved in the fatty acid synthetic pathway were downregulated
in response to PF. Four genes associated with exogenous fatty
acid incorporation during phospholipid membrane synthesis
in E. coli, including fadD, plsB, and plsC (Green et al., 1981;
Coleman, 1992; Yao and Rock, 2013), were upregulated in
response to PF (Supplementary Table S1), suggesting a shift
away from de novo phospholipid synthesis to conserve energy.
Our transcriptomic data also revealed a possible shift toward
short chain fatty acid degradation pathways, as eight genes
associated with the propionate degradation route of fatty acid
metabolism and four genes involved in malonate utilization
were upregulated in the presence of PF (Supplementary Table
S1). Phenotype microarray data further supported this in part,
revealing a 1.32-fold and 1.25-fold increase in growth of A118
in malonate and propionate, respectively, in the presence of PF
(Figure 2). Because propionate and malonate can serve as a
single carbon source through prp operon and acnB/D-mediated
conversion into PYR and succinate, where the latter can be
shuttled into the TCA to amplify energy production (Suvorova
et al., 2012), we hypothesized that the PF-induced shift to short
chain fatty acid degradation may contribute to the ability of
A. baumannii to persist within the host.
Other systems differentially expressed under PF induction
involved in PYR synthesis and utilization (Figure 1C) include
the phosphoenolpyruvate carbohydrate phosphotransferase
system and transamination. Ten aminotransferase genes were
upregulated, including the 1.58-fold upregulation of the φ-amino
acid PYR aminotransferase gene, peg.1151, which uses PYR
to transaminate a variety of α-amino acids, monoamines, and
diamines (Yonaha et al., 1983). gabT, which was upregulated
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FIGURE 1 | PF augments transcriptomic response of PYR metabolism-associated genes. (A) qPCR of A118 strain genes associated with the PDH complex, aceE,
and (B) aceF in the presence of PF. Fold changes were calculated using double MCt analysis. At least three independent samples were used, and four technical
replicates were performed from each sample. Statistical significance (∗P < 0.05) was determined by the Mann–Whitney t-test (n = 3 to 4). (C) DEGs associated with
PYR metabolism under exposure to PF. Red words and arrows indicate downregulated, statistically significant genes (adjusted P < 0.05). Green words and arrows
indicate upregulated, statistically significant genes (adjusted P < 0.05). Dotted arrows indicate DEGs that were not statistically significant. Black arrows indicate
genes that were not differentially expressed under PF treatment. Dashed lines indicate a second substrate utilized in the enzymatic conversion to next metabolite of
the pathway.
FIGURE 2 | Phenotype microarray. Heat map of phenotype microarray
demonstrating growth of Acinetobacter baumannii A118 strain, with and
without PF on selected carbon sources. L-tyrosine acted as a nitrogen
source, denoted by (N) (n = 1).
by 8.19-fold in the presence of PF, can also use PYR in its
transamination activity to produce succinate semi-aldehyde and
L-alanine (Supplementary Table S1).
Anaerobic utilization and synthesis of PYR are associated with
lactate metabolism. The lactate metabolism locus, which consists
of the L-lactate permease, two lactate dehydrogenases, and a
lactate response regulator (peg.3583–3586), was upregulated
by PF (Supplementary Table S1). L-lactate permease is
responsible for transporting lactate across the membrane, and
lactate dehydrogenase oxidatively converts lactate into PYR
(Figure 1C). In patients with severe pneumonia, anaerobic
metabolism and subsequent lactic acid levels are elevated
(Liu et al., 2015). This shift in metabolism increases the
availability of lactic acid, which may be used by A. baumannii
as a carbon source to produce PYR under PF induction.
However, growth curves did not demonstrate a significant
increase in bacterial growth in LB supplemented with PYR
(Supplementary Figure S3A) in the presence of PF. The
enhanced gene expression of PDH, lactate dehydrogenase,
propionate metabolism, and PYR aminotransferases suggest that
in the presence of PF, A. baumannii A118 displays a yet-unknown
strategy involving PYR.
PF and PYR Affect A. baumannii
Cytotoxicity Against Human Epithelial
Cells
The global differential expression of genes associated with
metabolism elicited by PF suggested a “survival strategy,” where
PYR’s role in energy production is secondary to an inducive
role of fortification and virulence. PYR has been reported
as an inducer of pathogenicity in S. aureus (Harper et al.,
2018); however, no study, to our knowledge, has reported
this phenomenon in Gram-negative pathogens linked with a
differential metabolic profile in response to a serous fluid. We
hypothesize that the metabolite triggers an adaptive response that
strengthens the ability of A. baumannii to cope with components
of PF that threaten survival (i.e., phagocytic, granulocytic, and
neutralization agents). To assess whether such an adaptive
response involves secretion of protein compounds or molecules
that enhance pathogenesis by impacting hosts components,
CFCM of A. baumannii A118 grown in LB with or without the
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addition of PF, either in the presence or in the absence of PYR,
was obtained and used in cytotoxicity assays.
Human epithelial cells (HeLa) were exposed to increasing
concentrations of CFCM isolated from A. baumannii A118
grown with or without PF, in the absence or presence
of 1% PYR as used before (Harper et al., 2018). For
both PF and PF + PYR conditions, we observed that as
the CFCM concentration increased, HeLa percent viability
decreased (Figure 3A). To assess the significance of the
observed effect, we compared the extent of the A. baumannii
A118 cytotoxicity with that of a control performed with
CFCM of S. aureus USA300, a bacterium known to secrete
several hemolytic and cytolytic peptides and leukocidins
that contribute to its potent virulence (Kobayashi et al.,
2011). Interestingly, we observed that while LB CFCM from
A. baumannii had minimal cytotoxicity, PF CFCM began
to approach S. aureus USA300 cytotoxicity levels at 12.5%
CFCM, thus demonstrating a PF-mediated enhancement of
A. baumannii A118 cytotoxicity. On the other hand, PYR
alone did not produce a dose-dependent cytotoxic effect
against HeLa cells. However, the combination of PF + PYR
indeed reduced HeLa viability below 50% once reaching a
concentration of 25% CFCM.
We observed the cytotoxic effect induced by S. aureus USA300
to plateau well below 50% viability after HeLa exposure to 1.56%
CFCM (Figure 3A). Therefore, this percentage (1.56% CFCM)
was used to determine relative pathogenicity of A. baumannii
under various study conditions. Viability of HeLa cells was
determined by the amount of ATP present. Interestingly, for both
the PF and PYR CFCM conditions, a minor 1.22-fold reduction
in ATP was observed, relative to LB CFCM (Figure 3B). When
A118 was induced by both PF and PYR, a significant 2.55-
fold reduction (P < 0.01) in viability occurred, suggesting that,
at non-saturating concentrations of CFCM (1.56%), both PF
and PYR effects simultaneously work to enhance A. baumannii
cytotoxicity against human epithelial cells (Figure 3B).
FIGURE 3 | PF and PYR enhance cytotoxicity of A118 against human epithelial cells and murine macrophages. (A) Percent viability of HeLa epithelial cells and
(C) RAW macrophages after 1-h intoxication with concentrations of A118 LB, PF, PYR, or PF + PYR CFCM from 0 to 50%. Viability proportions were determined as
the concentration of ATP in experimental treatments divided by the ATP concentration of untreated mammalian cells. Staphylococcus aureus USA300 was used as a
control to determine efficacy of experiment. (B) Viability, defined by ATP µM, of HeLa epithelial cells and (D) RAW macrophages upon treatment with 1.56% LB
broth, LB CFCM, PF CFCM, PYR CFCM, and PF + PYR CFCM. 70% ethanol (ETOH) was used as cell death control. LB broth was used for determining statistical
significance using one-way ANOVA analysis by Sidak’s comparison (n = 3–12; ∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.005; ∗∗∗∗P < 0.0001).
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To further assess the role of PF and PYR in A. baumannii
pathogenesis, we exposed RAW 264.7 macrophages to A118
LB CFCM, PF CFCM, PYR CFCM, and PF + PYR CFCM.
Macrophages are the most abundant white blood cell type in PF
and are the first responding immune effectors to A. baumannii
(Garcia-Patino et al., 2017). Consistently with the interaction
observed against HeLa, as CFCM concentrations increased,
the cytotoxic effect of PF and PF + PYR against RAW
macrophages also increased (Figure 3C). PYR CFCM alone did
not produce this effect.
Analysis of 1.56% CFCM conditions revealed a 2.4-fold
decrease in ATP of LB CFCM-exposed RAW cells (Figure 3D),
indicating that A118 constitutively secretes cytotoxic peptides
against murine macrophages. However, when A118 was induced
by PF, its CFCM triggered a drastic 9.06-fold reduction
(P < 0.01) in RAW cell viability, almost surpassing the 70%
ETOH cell death condition in mean ATP luminescence. We
observed only a slight reduction in ATP upon exposure to
PYR CFCM compared to LB CFCM. However, PF + PYR
CFCM resulted in a stronger decrease in RAW viability. This
suggests that the cytotoxic effects of peptides and molecules
secreted by A118 against RAW macrophages are amplified by
PF, but not by PYR.
Upon Exposure to PF, PYR Rescues
Persistence in A. baumannii-Susceptible
Strain A118
Persistent bacterial cells, which are a small subpopulation within
a susceptible population, can resist antibiotic action, causing
treatment failure and relapse of a bacterial infection without
having acquired a genetic resistance trait. Given the amplification
of cytotoxicity with PYR and PF against human epithelial
cells and the enhanced cytotoxicity observed against murine
macrophages with PF, we evaluated the occurrence of persister
cells upon exposure to a high concentration of antibiotics.
Persistence assays using high concentrations of OFX (3X MIC)
of A118 in LB, PF, LB + PYR, and PF + PYR were performed.
We observed that exposure to PF reduced production of persister
cells by 24.21-fold (Figure 4A). However, compared to PF
alone, PF supplementation with PYR increased the occurrence
of persister cells, indicating a rescuing role for PYR in presence
of PF (Figure 4A). These data suggest that PYR is used by
A118 to generate substrates that can modulate the formation of
persister cells, allowing it to survive in nutritionally depriving
environments such as PF.
To further test the effect of PYR and/or PF on persistence, A42
and AB5075 strains were also tested. In A42, supplementation
of LB with PYR significantly amplified persistence by 6.90-fold,
a trend similar to A118. However, unlike A118, PF seemed to
induce persistence in A42 (Figure 4B). We also observed a
decrease in persistence when PF was supplemented with PYR,
indicating an absence of the synergy observed in A118. Given
the intrinsic resistance possessed by A42, this suggests that the
amplifying persistence relationship of PF + PYR is a survival
mechanism used by more susceptible, less virulent strains
of A. baumannii.
In AB5075, we also observed a decrease in persistence when
PF was supplemented with PYR (Figure 4C), demonstrating
the same lack of synergy observed in A42. AB5075 is the
most resistant and virulent of the three strains used in our
model, and, compared to PF alone, the lack of persistence
amplification of PF supplemented with PYR suggests that the
synergy mechanism between the two substances has an effect only
in less pathogenic strains.
To study the effect of PF and PYR on A. baumannii virulence,
bacterial killing assays were performed against E. coli-TET-
resistant prey. A118 under the different treatments (LB, PF,
LB + PYR, and PF + PYR) was used as the predator to
test enhanced virulence and persistence by PF-PYR synergy
in clinically susceptible strains of A. baumannii. We observed
that A118 LB + PYR exhibited increase killing activity, by
400,000-fold, compared with LB alone (Figure 4D), and we also
observed the same level of killing activity of A118 grown in
PF with or without PYR supplementation (Figure 4D). Our
transcriptomic data further showed that three of the genes
encoding the type VI secretion system (T6SS), tssH, vgrG_1,
and vgrG_5, were upregulated. Recent studies have revealed
that TssH participates in translocation of TssB and TssC, two
components of the T6SS contractile tube sheath, into the
periplasm. Assembly, contraction, and subsequent release of
releasing its effector proteins (Hcp and VgrG) are essential for
the T6SS final purpose—specifically to kill bacterial competitors
in close proximity (Basler et al., 2012; Russell et al., 2014). The
strengthened ability of A118 to kill E. coli elicited by both PF
and PYR demonstrated that the combination of these two stimuli
contributes to the competitive advantage of A. baumannii. These
results are also in line with modulation of other A. baumannii
fitness traits such as the enhanced cytotoxicity (Figures 3A–D)
and the amplified persistence observed in A118 with PF and/or
PYR (Figure 4A).
An Alternate PA Catabolic Pathway Is
Favored Under PF Induction of
A. baumannii
The PAA catabolic pathway is well studied in A. baumannii
and contributes to host immune effector evasion and virulence
(Teufel et al., 2010; Bhuiyan et al., 2016; Kroger et al., 2016).
The paa locus is regulated by global virulence regulators, such as
GacS and H-NS (Teufel et al., 2010; Bhuiyan et al., 2016; Kroger
et al., 2016). Our transcriptomic data revealed that all but three
genes of the paa locus were downregulated under PF induction
(Supplementary Table S1). The genes encoding monoamine
oxidase (peg.705) and phenylacetylaldehdye dehydrogenase
(feaB) were downregulated, suggesting that PA oxidation to PAA
and its subsequent catabolism are not favored in the presence
of PF. This was further substantiated by the downregulation of
the genes encoding succinyl-CoA synthetase and succinyl-CoA
ligase (Supplementary Table S1), which are responsible for TCA
cycle utilization of succinyl-CoA, a final product of the PAA
catabolic pathway.
qPCR of paaA, revealed a 2.28-fold decrease (P < 0.05) in
transcription with or without PF (Figure 5A). In A. baumannii,
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FIGURE 4 | Pyruvate’s role in persister cell formation, and PYR and PF increase bacterial killing activity of strain A118. (A) Percentage of surviving cells in LB, PF,
LB + 1% PYR, and PF + 1% PYR of strain A118, (B) strain A42, and (C) strain AB5075. Persister cells are defined as the number of surviving cells after treatment
with OFX divided by the number of surviving cells after treatment with water. Statistical significance (∗P < 0.05; ∗∗P < 0.005) was determined using unpaired t-test
(n = 3), comparing LB vs. PYR and PF vs. PF + PYR. (D) Bacterial killing assay using Escherichia coli TOP10-TET (prey) and A118 (predator) grown under the
different treatments (LB, PF, LB + 1% PYR, and PF + 1% PYR). Differences in survival of bacterial (E. coli-TET prey) colonies are shown in log2CFU/ml. Statistical
significance was determined using one-way ANOVA analysis (∗P < 0.05; ∗∗P < 0.01; ∗∗∗P < 0.005; ∗∗∗∗P < 0.0001), and experiments were performed in triplicates.
1paaA, and 1paaE deletion mutants were unable to grow in
L-PA as sole carbon source (Cerqueira et al., 2014). Considering
that the PAA catabolic pathway is a substantial shuttle for
PA degradation, we expected PA to be an unfavorable growth
substrate under PF induction. The 24-h growth curves of
A. baumannii strain A118 in 0.2% PA minimal media revealed
a slight reduction in growth between LB and PF conditions, and a
minimal growth in 0.2% PAA for both conditions (Figure 5B).
However, our phenotype microarray revealed that when L-PA
was used as the sole carbon source, OD590 values of PF-induced
cells were sustained (Figure 2). This can be attributed to the
upregulation of three of the five aromatic amino acid transporters
(Supplementary Table S1) that can take up PA.
Sustained growth in L-PA, despite the RNA-seq
downregulation of peg.705, feaB, and the paa locus, suggests that
A. baumannii utilizes an alternative pathway for PA catabolism.
This was supported by the qPCR for paaA gene expression, as
well as the sustained growth of A118 when LB was supplemented
with 0.2% PA, but a lack of growth when supplemented with PAA
(Figure 5C). Our data also suggest the presence of an alternative
pathway in strains A42 and AB5075, which displayed similar
patterns of growth when PA was used as sole carbon source
(Supplementary Figures S3B,C).
A feasible alternative route for PA catabolism is its
transamination to PP. We found two genes, peg.2520 and
peg.3587, encoding proteins with PA transamination activity
that were upregulated in the presence of PF. When PP was
used as a sole carbon source, we observed a decrease in
growth of PF-induced samples (Figure 5B), and when LB
was supplemented with 0.2% PP, the growth pattern did not
change (Figure 5C). The reduction in growth in PP + PF
minimal media may be attributed to the energy barrier associated
Frontiers in Microbiology | www.frontiersin.org 9 July 2019 | Volume 10 | Article 1581
fmicb-10-01581 July 15, 2019 Time: 15:26 # 10
Rodman et al. Pleural Fluids Alters A. baumannii Pathoadaptabililty
FIGURE 5 | PA alternative utilization changes due to PF induction and its impact on human neutrophil chemoattraction. (A) qPCR of A118 paaA in the presence of
PF. (B) Minimal media growth curves of strain A118 in 0.2% PA, 0.2% PAA, or 0.2% PP with or without PF. (C) Growth curves of strain A118 in LB supplemented
with 0.2% PA, 0.2% PAA, or 0.2% PP with or without PF (n = 3). (D) qPCR of A118 hpd. For both real-time qPCRs, fold changes were calculated using double MCt
analysis, and at least three independent samples were used with four technical replicates performed from each sample. Statistical significance (∗P < 0.05) was
determined by Mann–Whitney t-test (n = 3 to 4). (E) Genes differentially expressed by PF connected to PA catabolism. Red words and arrows depict statistically
significant downregulated genes (adjusted P < 0.05). Green words and arrows depict statistically significant upregulated genes (adjusted P < 0.05). Dotted arrows
indicate DEGs that were not statistically significant. Black arrows indicate genes that were not differentially expressed under PF treatment. Dashed arrows following a
metabolite indicate substrates that showed increased utilization in phenotype microarrays by A118 and lack a correlating differential gene expression in
transcriptomic data. (F) Growth curves of strain A118 in LB supplemented with 0.02% PA, 0.02% PAA, or 0.02% PP with or without PF. 0.02% was selected as the
concentration for PA and its derivatives for testing in order to mimic the mean concentration of amino acid nitrogen in normal human blood (Schaeffer et al., 1975;
Lamonica et al., 2012). Statistical analysis was performed using Mann–Whitney (n = 3). (G) Chemotaxis index of human neutrophils toward LB, 0.02% PA in LB,
0.02% PAA in LB, and 0.02% PP in LB in ex vivo Transwell migration assays. LB broth was used to determine statistical significance (∗P < 0.05) with one-way
ANOVA by Sidak’s comparison (n = 3). (H) Chemotaxis index of human neutrophils of A118 0.02% PA CFCM, 0.02% PAA CFCM, or 0.02% PP CFCM with or
without PF induction. Statistical significance (∗P < 0.05) was performed using two-way ANOVA by Tukey’s comparison (n = 3), where bracketed bars with (∗)
represent statistically significantly different index means. Single bars with (∗) represent statistically significant by comparison compared to controls. All ex vivo
Transwell migration assay chemotaxis indexes were determined by dividing number of live neutrophils that migrated to the experimental condition (PA, PAA, PP, PA
CFCM, PAA CFCM, and PP CFCM) divided by number of live neutrophils that migrated to LB broth.
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with favoring alternative pathways of PA degradation other
than the PAA catabolic route [42], which involve oxidative
decarboxylation of PP to phenylacetylaldehdye, phenylacetate,
hydroxyl-3-phenylpropionate, and/or 2-hydroxyphenylacetate.
Among the four possible routes, only the gene encoding 4-
hydroxyphenylpyruvate dioxygenase, the enzyme responsible for
2-hydroxyphenylacetate formation, was differentially expressed.
The corresponding gene, hpd, peg.2560, was upregulated by
1.83-fold in PF (Supplementary Table S1). The qPCR of hpd
revealed a 20.9-fold increase in LB+ PF transcripts (Figure 5D).
Considering our transcriptomic results, A118 in the absence of
PF may not favor PP conversion to 2-hydroxyphenylacetate via
hpd, and the increased growth pattern of PP (Figure 5B) can be
attributed to a preferential shift toward the three other possible
routes that may be more energetically efficient (Figure 5E).
2-Hydroxyphenylacetate is both a substrate in tyrosine
metabolism and styrene degradation. A central part of styrene
degradation is the production of homogentisate from 2-
hydroxyphenylacetate and 3-hydroxyphenylacetate, followed by
a conversion to 4-maleylacetoactate. The enzymes responsible for
this process have not been described in A. baumannii; however,
in our phenotype microarray, we found a 1.39-fold increase in
growth for A118 PF in 3-hydroxyphenylacetic acid (Figure 2).
We also observed a 1.19-fold increase in growth in L-tyrosine
as an additional nitrogen source (Figure 2), suggesting that
production and utilization of 2-hydroxyphenylacetate are favored
in the presence of PF for A118.
The next step of styrene degradation is the isomerization of 4-
maleyacetoacetate to fumarylacetoacetate via malelylacetoacetate
isomerase. Fumarylacetoacetate is then cleaved by
fumarylacetoacetase into fumarate and acetoacetate to be
shuttled into the TCA cycle and propionate metabolism,
respectively. The genes encoding both malelylacetoacetate
isomerase (peg.2257), fumarylacetoacetase (peg.2556), and
fumarate hydratase class I (fumA, peg.2808) were upregulated
by PF, and propionate metabolism was shown to be favored
under PF induction (Supplementary Table S1 and Figure 2).
Moreover, growth of A118 PF was 1.32-fold higher when
grown on acetoacetic acid (Figure 2). Altogether, these results
suggest an alternative pathway for PA degradation through
the transamination to PP with the derivatives of the pathway
shuttling the TCA cycle and propionate metabolism, rather than
the use of the PAA catabolic route (Figure 5E).
PF’s Impact on PA Catabolism Triggers a
Neutrophil-Evasive State in A. baumannii
Recently, the A. baumannii PAA degradation route of PA
was reported to play a significant role in the mediation of
neutrophil chemotaxis. PAA was found to be a powerful
neutrophil chemoattractant in ex vivo experiments of mouse-
derived neutrophils, and 1paaA deletion mutants increased
in vivo neutrophil migration and dwelling in zebrafish15. With
these findings in mind, we hypothesized that under PF induction,
the combined down- and upregulation of the PAA and PP
degradation routes of PA, respectively, inhibits the accumulation
and release of PAA in strain A118. Hence, this relatively
avirulent strain would then be able to make use of the energetic
advantages of host-derived PA degradation using the proposed
alternative PA pathway while simultaneously reducing host
neutrophil recruitment.
To evaluate the role of PA metabolism in neutrophil
recruitment, we performed ex vivo neutrophil chemotaxis assays
using human-derived primary neutrophils. Growth curves of
PA and its derivatives revealed no significant changes in the
growth pattern between PA + LB and PA + PF (Figure 5F),
indicating that addition of the essential amino acid (PA) in the
presence of PF may have an effect beyond growth augmentation
given our RNA-seq data. All conditions reached stationary phase
above 1.0 OD600 within 5 h; however, a 1.37-fold reduction in
growth for A118 0.02% PP+ PF was observed at stationary phase
compared to all other conditions. This pattern is consistent with
the reduction observed in minimal media testing (Figure 5B),
indicating that the PP alternative pathway may not be the
most energetically optimal route. Therefore, we hypothesize
that the growth pattern during the lag phase represents the
quick degradation of PP followed by a less energetically efficient
process of shuttling alternative pathway intermediates to growth-
promoting energy processes. Despite the limited efficiency, the PP
alternative route may be the most favorable in terms of survival
in the host as it limits PAA accumulation.
In the ex vivo chemotaxis assays, when LB was supplemented
with PA, PAA, or PP, neutrophil migration increased by more
than 2-fold compared to LB for both PA and PAA conditions.
Interestingly, in the presence of PP, chemotaxis increased by 4-
fold (Figure 5G). These results suggest that the alternative PA
pathway induced by PF is a peripheral response to uptake and
degrade PP to prevent neutrophil recruitment and may account
for the significant upregulation of hpd.
When neutrophil chemotaxis assays were performed using
A118 CFCM, PA + PF CFCM resulted in a significant 2.01-fold
reduction in neutrophil migration compared to PA + LB CFCM
(Figure 5H), confirming our hypothesis that PF triggers the
incorporation of exogenous PA while simultaneously prompting
a neutrophil evasive state. Therefore, the proposed alternative
pathway for PA catabolism is most likely a selective process
that is strengthened by the uptake and degradation of PP.
While not as energetically efficient as the PAA pathway, this
alternative strategy probably exerts the largest survival payoff—
neutrophil evasion. This is especially highlighted in the 2.21-fold
reduction in chemotaxis for PP + PF CFCM (Figure 5H). In
fact, PP + LB CFCM chemotactic levels matched that of PP
control, indicating that PP uptake and degradation by A118 are
not favored in the absence of PF. This is further illuminated
by the slightly higher chemotaxis observed in PF + PAA
CFCM compared to PA + PF CFCM and PP + PF CFCM,
which may account for the downregulation of the paa operon
and subsequent PAA catabolic route. However, PF + PAA
CFCM still demonstrated a reduction in chemotaxis by 1.46-
fold compared to LB + PAA CFCM, which may be attributed to
PAA’s relationship to tyrosine metabolism, to which we observed
higher growth in the phenotype microarray (Figures 1A, 5E).
These results represent a significant finding, as neutrophils are
considered key actors in A. baumannii infection clearance [39].
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The potential reduction of bacterial metabolite chemoattractant
observed under the influence of a serous fluid not only highlights
the pathoadaptability of A. baumannii but also establishes a link
between metabolism and virulence/persistence features.
The Expression of Additional Genes
Involved in Central Metabolism Is Also
Affected by PF in A. baumannii Strain
A118
Analyzing the transcriptomic data related with metabolic
processes and focusing our analysis on genes involved
in central metabolism, we observed that 13 of the 17
DEGs linked to the tricarboxylic acid (TCA) cycle were
downregulated upon PF exposure (Supplementary Table S1
and Figure 6A). Interestingly, 11 of the 12 genes involved
in the stepwise formation of fumarate from citrate were
downregulated (Figure 1B), including aconitate hydratase
I (peg.2864), isocitrate dehydrogenase (peg.1442/4), the
2-oxoglutarate dehydrogenase complex (peg.2938–40),
succinyl-CoA synthetase (peg.712), succinyl-CoA ligase
(peg.2936–37), and succinate dehydrogenase (peg.2941–
44). Following the production of fumarate, all aerobic
enzyme-associated genes of the TCA cycle were upregulated,
including fumarate hydratase class I (peg.2808) and MDH
(peg.2148). However, the fumarate hydratase class II (peg.845),
the fumarase favored under oxidative and iron-limiting
stress, and two of three genes encoding C4-dicarboxlayte
transporters, peg.1092 and peg.355, were downregulated by PF
(Supplementary Table S1).
These transcriptional changes were confirmed by our
phenotype microarray data, which showed a reduction in
bacterial growth rate when citric acid, succinic acid, and α–
ketoglutaric acid (the conjugate base of 2-oxoglutarate) were used
a sole carbon sources, and an increase in bacterial growth rate
when racemic or L-malic acid were used as sole carbon sources
for LB+ PF-induced cells (Figure 2).
The 2-oxoglutarate dehydrogenase complex was selected
for dehydrogenase activity testing due to 2-oxoglutarate’s link
to glutamate metabolism, which we hypothesized to be a
significant pathway in A. baumannii’s response to PF due to
the profound growth observed on L-glutamic acid (Figure 2).
A118 transcriptomic data revealed that 14 genes associated with
glutamate metabolism were upregulated in the presence of PF
(Supplementary Table S1). The upregulation of gdh (peg.2261)
in particular may account for the higher NADH formation (1.4-
fold increase) observed when soluble extracts of A118 incubated
with PF were supplemented with 2-oxoglutarate (Figure 6B)
despite the downregulation of the 2-oxogluatrate complex,
for glutamate dehydrogenase is responsible for 2-oxoglutarate
conversion to glutamate.
Glutamate metabolism plays an essential role in the microbial
response to acid and oxidative stress, particularly through
γ-aminobutyrate (GABA) catabolism (Feehily and Karatzas,
2013). GABA is a known component of the GABA shunt,
which utilizes glutamate to produce succinate, bypassing certain
steps of the TCA cycle. Remarkably, the gene encoding
γ-aminobutyrate-α-ketoglutarate aminotransferase (GABA-T),
peg.2412, was upregulated by 8.18-fold in response to PF. This
upregulation was phenotypically confirmed by the higher OD590
observed when γ-aminobutyrate was used as the sole carbon
source (Figure 2). As the more virulent strains of A. baumannii
(A42 and AB5075) did not exhibit statistically significant
increases in NADH formation in 2-oxoglutarate dehydrogenase
assays in the presence of PF (Figure 6B), our results suggest a
strain-specific secondary pathway for 2-oxoglutarate utilization
favoring glutamate metabolism in less virulent A. baumannii
strains. Further studies including more low virulent strains are
needed to support the premise presented.
In addition, the mdh (MDH) genes (peg.2148) and a malic
acid transporter encoding gene (peg.2533) were upregulated
(Supplementary Table S1). MDH assays showed statistically
significant increases in NADH production for both A118
(2.56-fold) and A42 (1.65-fold) strains in the presence of PF,
while AB5075 demonstrated a slight reduction (Figure 6C).
Interestingly, growth curves of PF-induced A. baumannii in
L-malic acid demonstrated an extended lag phase in A118 that
diminished in A42 and was absent in AB5075 (Figure 6D).
We stress that among the three tested strains, A118 is the
most susceptible and least virulent, A42 is mildly susceptible
and virulent, and AB5075 is the most resistant, highly virulent
strain (Table 1), and subsequently, as pathogenicity increased,
PF-induced MDH activity significantly reduced and the lag
phase in L-malic growth curves shortened. Taken together, these
observations suggest that malate is a significant substrate in
a strain-specific metabolic persistence strategy elicited by PF
similar to that observed in PYR-induced persister formation.
DISCUSSION
PF-Induced Metabolic Strategies and
Survival
Acinetobacter baumannii is known to be an extremely adaptable
pathogen due to its genome plasticity, as well as its metabolic
versatility upon exposure to host effectors. In the presence
of mucin, a glycoprotein secreted by lung epithelial cells,
virulence features associated with the paa operon, as well
benzoate metabolism, amino acid and lipid catabolism, electron
transport activity, and peptide transport are upregulated (Ohneck
et al., 2018). HSA, a component of PF, was previously
reported to promote expression of arginine metabolism and
succinyl-CoA production genes, to which the latter was linked
to polypetide biosynthesis, a metabolite that can confer a
competitive advantage during pathogenesis (Allen and Gulick,
2014; Quinn et al., 2018c).
In this work, we observed a profound transcriptional response
elicited by PF, especially within genes involved in metabolism
in A. baumannii A118, which suggests a metabolically driven
strategy for survival during respiratory infection. This included
opposing transcriptional responses in lipid metabolism genes
characterized by downregulation of lipid biosynthesis and
upregulation of short chain fatty acid (propionate) degradation.
Based on the observed downregulation of genes associated
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FIGURE 6 | Continued
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FIGURE 6 | PF induces changes in expression of genes involved in metabolism. (A) Genes differentially expressed by PF linked to the TCA cycle and GABA shunt.
Red words and arrows depict statistically significant downregulated genes (adjusted P < 0.05). Green words and arrows depict statistically significant upregulated
genes (adjusted P < 0.05). Dotted arrows indicate DEGs that were not statistically significant. Black arrows indicate genes that were not differentially expressed
under PF treatment. Dashed lines indicate a second substrate utilized in the enzymatic conversion to next metabolite of the pathway. (B) 2-oxoglutarate
dehydrogenase (ODH) activity of the cell soluble extracts of three model strains, indicated by relative fluorescent units (RFU). RFU values were recorded with an
excitation of 340 and emission of 460 to qualify NADH formation, indicating activity of the dehydrogenase. Statistically significant results (∗P < 0.05; multiple t-test;
n = 3–6). (C) Minimal media (MM) growth curves of strains A118, A42, and AB5075 in 0.2% malate and 0.2% fumarate with or without PF. Mann–Whitney statistical
analysis was performed to analyze all growth assays (P < 0.05; n = 3). (D) Malate dehydrogenase (MDH) activity of cell soluble extracts of the three model strains of
Acinetobacter baumannii. Statistically significant results (∗P < 0.05; multiple t-test; n = 3–6).
with fatty acid synthesis, we propose that A. baumannii may
obtain fatty acids from PF to exert negative feedback on ACC
and the FASII system to reduce de novo lipid biosynthesis
in A. baumannii.
In this study, PF induction also revealed a relationship
between PYR, a critical factor in energy production and central
sugar metabolism, to different modes of survival. We showed that
the addition of PYR alters cytotoxic activity of secreted molecules
against human epithelial cells (Figures 3A,B). In S. aureus,
PYR causes global changes to the exoproteome that were then
correlated to enhanced cytotoxicity against polymorphonuclear
neutrophils (Harper et al., 2018). Sensor kinase two-component
systems (SK-TCS) conserved in the Staphylococcus genus were
implicated in this modulation of virulence; accordingly, we
propose that host-derived PYR activates sensory systems that
work in conjunction with the effects of PF on the global
regulation of A. baumannii’s virulence.
By implicating PYR in the A. baumannii survival strategy,
this study strikingly demonstrates an essential link to the
pathogen’s adaptable physiology, as this metabolite is essential
not only for host energy production but also for maintaining
neutrophil immunonutrition (Mathioudakis et al., 2011). When
testing the role of PYR in antibiotic persistence, we found that
as the pathogenicity of the tested strain increases (antibiotic
resistance and virulence), the positive rescue effects of PYR
decrease in the presence of PF. Opposing metabolic strategies
between resistant and susceptible strains of A. baumannii have
been previously reported, specifically within TCA metabolite
abundance levels using untargeted metabolomics. Maifiah et al.
(2016) found that polymyxin-susceptible strains revealed higher
abundance of early TCA cycle intermediates, while resistant
strains demonstrated higher abundance of late TCA cycle
intermediates (Maifiah et al., 2016). Our TCA cycle differential
expression analysis revealed an upregulated transcriptomic
response toward late cycle intermediates. We also observed
a similar strain-specific strategy in MDH activity as the
effect observed in the antibiotic persistence model upon the
addition of PYR.
The reduced pathogenicity together with increased
metabolic activity for PYR utilization provide an interesting
link between differential metabolism, persistence, and
virulence. The observed correlation between PF-mediated
modulation of MDH activity and A. baumannii pathogenicity
indicates the divergence in survival strategies between
different strains, as the enzyme and its substrates are
correlated to biofilm production (Shin et al., 2009) and
are connected to the end products of the proposed
alternative PA catabolism pathway for neutrophil immune
evasion (Figure 5E).
Immune Evasion Strategy Stimulated by
PF
Neutrophils are extremely potent immune effectors against
pathogens and are necessary to coordinate an effective response
to various immune cells (Mccracken and Allen, 2014). The
granulocytes are essential agents against A. baumannii infection,
as the bactericidal mechanisms of nitric oxide synthase 2
and NADP oxidases have been shown to be critical in
host protection from the pathogen (Qiu et al., 2009). In
murine respiratory infection models, neutrophil depletion
resulted in lethal A. baumannii infections with enhanced
bacterial burdens of the lung that were associated with
delayed production of pro-inflammatory cytokines such as
tumor necrosis factor-α (TNF-α, interleukin-6 (IL-6), KCP,
monocyte chemoattractant protein-1 (MCP-1), and macrophage
inflammatory protein-2 (MIP-2) (Van Faassen et al., 2007;
Tsuchiya et al., 2012). Therefore, A. baumannii evasion against
these potent effectors would be extremely advantageous in the
survival of the pathogen.
Bhuiyan et al. (2016) reported that the metabolic by-
product of the paa catabolic pathway of PA has a significantly
positive neutrophil chemotactic effect. Therefore, the proposed
alternative PA degradation pathway induced by PF in A118
constitutes a feasible immune evasion strategy against
neutrophils in A. baumannii.
The dramatic 4-fold increase in chemotaxis of neutrophils
in PP + LB and subsequent reduction in the A118 CFCM
induced by PF suggest that PP is a significant immunoregulatory
metabolite in human neutrophils. Macrophage migration
inhibitory factor (MIF) is a PP tautomerase cytokine that
uses PP and p-hydroxyphenylpyruvate as substrates during
the innate immune response (Rosengren et al., 1996, 1997).
MIF has been hypothesized to play an essential role in innate
immunity regulation, as its production has been shown to be
induced by Gram-negative endotoxins, TNF-α and interferon-γ
(INF-γ) (Calandra and Roger, 2003). The cytokine promotes the
expression of a number of proinflammatory molecules including
cytokines, NO, matrix metalloproteinases, COX-2, and other
arachidonic acid pathway products (Mitchell et al., 1999, 2002).
In fact, rat in vivo models have directly correlated MIF to the
accumulation of activated neutrophils through regulation of
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FIGURE 7 | Theoretical model of Acinetobacter baumannii neutrophil evasion strategy elicited by PF. In the host respiratory space, A. baumannii encounters PF,
inducing a survival-based transcriptional response. PA uptake and alternative catabolism toward styrene degradation are amplified to prevent PP accumulation. The
halting of PP release inhibits PF-resident macrophages from utilizing the phenylpyruvate tautomerase cytokine macrophage inhibitory factor (MIF). Lack of active MIF
reduces mobilization of MIP-2, a known neutrophil recruiting cytokine. Concurrently, the PAA catabolic route for PA degradation is downregulated to prevent bacterial
metabolite-driven neutrophil chemoattraction. Resident respiratory space macrophages (pictured as alveolar macrophages) are then targeted by secreted cytotoxic
exoproteins induced by PF, preventing pathogen recognition and subsequent secretion of proinflammatory chemokines such as CXCL-1, MIP-2, IL-1α, and MCP-1.
Simultaneously, host-derived PYR is sensed by a membrane two-component system transport protein (PYR-TCS) to be used in conjunction with the effects of PF to
produce epithelial cell-specific cytotoxic proteins. Epithelial cell (pictured as lung epithelial cells) inflammatory response is then reduced, inhibiting second-wave
neutrophil recruitment. Red inhibitory lines represent downregulated/inhibited processes. Green arrows and proteins represent upregulated processes.
MIP-2 (also known as CXCL-2), a neutrophil chemoattractant
cytokine (Baugh and Bucala, 2002).
Given that macrophages constitute 75% of the white
blood cell count of PF, we propose that the amplified
PP degradation and reduced chemotaxis obtained under PF
induction are direct responses by A. baumannii to reduce
MIF’s substrate availability. Therefore, by upregulating tyrosine
and PA alternative metabolism, the pathogen can prevent
neutrophil activation and recruitment by reducing macrophage
cytokine signaling.
Neutrophils are produced and stored in large reserves in the
bone marrow, ready to be deployed into the circulation upon
cytokine stimulation (Yamashiro et al., 2001). Therefore, tissue
resident macrophages are the first innate immune effectors to
respond to infection. These cells are less immunoreactive than
neutrophils, making their primary purpose to signal for more
potent immune effectors (Davies and Taylor, 2015). In fact,
alveolar macrophages were shown to require 24 more hours to
phagocytose and kill 80% of A. baumannii, while neutrophils
were able to clear A. baumannii within 1 h (Qiu et al., 2009).
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However, the same study demonstrated enhanced susceptibility
of mice to A. baumannii challenge during in vivo depletion of
alveolar macrophages. This can be attributed not only to the
bactericidal activity of macrophages but also to the activation
of the secretion of neutrophil-recruiting chemokines such as
CXCL-1, MIP-2, IL-1α, and MCP-1 (Beck-Schimmer et al., 2005;
De Filippo et al., 2008; Barry et al., 2013). Strains resistant to
early innate immune factors, like tissue-resident macrophages,
have been shown in A. baumannii to enhance bacterial burden
in vivo and have been correlated to the virulence state (Bruhn
et al., 2015). Therefore, the enhanced cytotoxicity of PF-induced
A118 CFCM against macrophages (Figures 3C,D) could be a
survival strategy not only to prevent killing but also to prevent
the recruitment of the more potent neutrophil. Accordingly,
our observations provide evidence of novel mechanisms of
pathoadaptability of A. baumannii using host signals to modify
its virulence state.
The first line of infection is the epithelial cell, and
cytoadherence, which is an important process in A. baumannii
virulence (Mortensen and Skaar, 2012), has been pointed out as
a significant stimulus for the production of proinflammatory
cytokines in human lung epithelial cells (Yang et al.,
2003). Cytoadherence, while enhancing the pathogenesis
of A. baumannii infection, can be disadvantageous due to
the apoptotic factor signaling of phagocytic effectors. By
releasing cytotoxic exoproteins, A. baumannii would have the
opportunity to promote its survival by preventing invasion-
induced sacrificial apoptosis, as well as the recruitment of
activated innate immune effectors. Therefore, the enhanced
cytotoxicity effect observed against epithelial cells may be the first
component of a neutrophil evasion strategy during A. baumannii
respiratory infection.
For both PYR and PA, we showed how acquiring these
metabolites from the external environment aids A. baumannii’s
survival and virulence and proposed that they are used under
the induction of PF to promote a neutrophil immune evasion
during respiratory infection (Figure 7). Interestingly, both PYR
and PA have a metabolic pathway connected to propionate
metabolism via acetyl-CoA interconversion to malonate
semialdehyde and PP conversion to fumarylacetoacetate,
respectively (Figures 1C, 5E). Propionate and many of
the intermediates associated with its biosynthesis, including
acetoacetic acid, malonic acid, and L-valine, were observed to
have increased utilization in the presence of PF (Figure 2 and
Supplementary Figure S4), and we observed an upregulation
of propionate metabolism genes (Supplementary Table S1).
Propionate has been shown to dampen the cytokine and
nitric oxide response of mouse and human monocytes and
macrophages to microbial stimulation (Ciarlo et al., 2016).
Considering the short chain fatty acid’s connection to both
PA and PYR metabolism under PF induction observed here,
propionate may serve as a central link for further exploration
into our proposed immune evasion strategy enacted by
A. baumannii.
In the present work, we mimic aspects of bacterial–host
interactions by exposure to PF and observed that A. baumannii
cytotoxicity and immune evasion are enhanced in response
to changes in intracellular PYR and PA metabolism. The
differential expression of genes involved in these metabolic
processes was also affected upon PF exposure, leading to
enhanced cytotoxicity against human cells and weakened
human neutrophil chemotaxis, as well as the augmented
occurrence of persister cells. Together, these results indicate
that metabolism, immune evasion, and persistence strategies
exhibited by A. baumannii exist on a multidimensional axis
linked by external environmental signals in response to a harsh
host environment.
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FIGURE S1 | Bioinformatic analysis of RNA-seq data from LB- or 4% PF-treated
Acinetobacter baumannii A118. (A) PCA plot of all RNA-seq samples. Biological
replicates of the same treatment are indicated by color in the legend. (B) Heat
map of the expression profiles of the 500 most highly expressed genes based on
DESeq log2 transformation of read count data. Gene- (rows) and sample-wise
(columns) clustering dendrograms are shown.
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FIGURE S2 | Differential gene expression of Acinetobacter baumannii A118 in
response to PF. Volcano plot showing log2fold changes vs. P-value for all genes of
A. baumannii A118. Black dots depict genes with differences below the threshold
limit of significance (adjusted P < 0.05), indicated by a blue dashed line. Genes
within the area of statistically significant differential downregulation or upregulation
higher than 2-fold change are depicted as red and green dots, respectively. Genes
within the area of statistically significant differential downregulation or upregulation
between 1.5- and 2-fold change are depicted as light red and light green dots,
respectively. Dots corresponding to genes involved in all metabolic pathways
described in this analysis are outlined in blue. Dots corresponding to specific
pathways of interest are highlighted in the indicated colors.
FIGURE S3 | Growth curves under PF induction. (A) A118 grown in LB broth
supplemented with 1% PYR with or without PF. (B) A42 grown in minimal media
supplemented with 0.2% PA and 0.2% PAA with or without PF. (C) AB5075 grown
in minimal media supplemented with 0.2% PA and 0.2% PAA with or without PF.
Mann–Whitney statistical analysis was performed analyzing all growth assays
(P < 0.05; n = 3).
FIGURE S4 | Heat map of phenotype microarray. (A,B) A118 growth with or
without PF induction on sole carbon sources and (C) sole nitrogen sources.
TABLE S1 | Genes associated with metabolic processes with differential
expression in Acinetobacter baumannii strain A118 under PF induction.
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